Vanguard Portfolio Management’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-82,301
Closed -$305K 3225
2026
Q1
$305K Buy
+82,301
New +$346K ﹤0.01% 3012

Other funds holding RCEL

Vanguard Portfolio Management's RCEL Position: Q2 2026 in Review

Vanguard Portfolio Management sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 82,301 shares — an estimated $305K sold.

Vanguard Portfolio Management first reported a position in RCEL in Q1 2026 and held it in 1 quarter. The position peaked at $305K in Q1 2026. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Vanguard Portfolio Management reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • Vanguard Portfolio Management sold 82,301 Avita Medical shares in Q2 2026, an estimated $305K.
  • Vanguard Portfolio Management first reported a position in Avita Medical in Q1 2026 and held it in 1 quarter.
  • Vanguard Portfolio Management's Avita Medical position peaked at $305K in Q1 2026.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.